Key Record Dates
ClinicalTrials.gov Identifier: | NCT03842228 |
---|---|
Brief Title: | Testing the Combination of the Anti-cancer Drugs Copanlisib, Olaparib, and MEDI4736 (Durvalumab) in Patients With Advanced Solid Tumors With Selected Mutations |
First Submitted : | February 7, 2019 |
First Submitted that Met QC Criteria : | February 13, 2019 |
First Posted : | February 15, 2019 |
Last Update Submitted that Met QC Criteria : | November 29, 2022 |
Last Update Posted : | November 30, 2022 |